Production (Stage)
Entrada Therapeutics, Inc.
TRDA
$7.59
-$0.26-3.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.83% | 19.33% | 27.08% | 24.67% | -20.46% |
| Total Receivables | -94.21% | -27.69% | -38.91% | 76.40% | 460.93% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 95.71% | 38.51% | -46.64% | 76.77% | 0.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.65% | 19.00% | 21.48% | 25.46% | -4.60% |
|
|
|||||
| Total Current Assets | -2.65% | 19.00% | 21.48% | 25.46% | -4.60% |
| Net Property, Plant & Equipment | -12.08% | -11.47% | -11.05% | -11.65% | 280.53% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.59% | -37.18% | -32.25% | 4.66% | -62.28% |
| Total Assets | -4.77% | 12.18% | 14.34% | 17.81% | 7.42% |
|
|
|||||
| Total Accounts Payable | -13.42% | 29.97% | 71.81% | -32.49% | -60.97% |
| Total Accrued Expenses | -16.79% | 19.21% | 43.59% | 68.04% | 15.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -21.58% | -4.43% | 16.50% | 15.63% | 16.87% |
| Total Finance Division Other Current Liabilities | -98.04% | -88.81% | -67.10% | -40.50% | 22.02% |
| Total Other Current Liabilities | -98.04% | -88.81% | -67.10% | -40.50% | 22.02% |
| Total Current Liabilities | -89.40% | -75.14% | -57.32% | -31.87% | 17.85% |
|
|
|||||
| Total Current Liabilities | -89.40% | -75.14% | -57.32% | -31.87% | 17.85% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.15% | -14.38% | -14.18% | -14.85% | 537.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -96.80% | -15.58% | -24.20% | -89.16% | -89.46% |
| Total Liabilities | -71.34% | -56.95% | -44.56% | -47.04% | -1.82% |
|
|
|||||
| Common Stock & APIC | 27.76% | 27.66% | 27.59% | 27.49% | 3.73% |
| Retained Earnings | 14.45% | 33.66% | 29.64% | 47.28% | 12.05% |
| Treasury Stock & Other | 277.64% | -122.05% | 295.97% | 67.26% | 61.68% |
| Total Common Equity | 54.90% | 76.88% | 71.26% | 107.79% | 17.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 54.90% | 76.88% | 71.26% | 107.79% | 17.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 54.90% | 76.88% | 71.26% | 107.79% | 17.31% |
|
|
|||||